IAC Express 2006 |
|
Issue number 623: October 2, 2006 |
|
|
|
|
Contents
of this Issue |
-
Study of more
than 2 million children fails to link MMR or DTP vaccination with
increased risk for encephalopathy
-
How's your
state doing? 2005 BRFSS provides influenza and pneumococcal vaccination
rates for adults age 65 and older
- Congratulations!
Dr. Nancy Cox, CDC influenza expert, selected as Federal Employee
of the Year
- Cardiologists
strongly encouraged to vaccinate their patients with inactivated
influenza vaccine
- Updated for
2006-07: Online information and guidance on influenza vaccine, antivirals,
lab diagnosis, and more
- Advisory Committee
on Immunization Practices (ACIP) meeting scheduled for October 25-26
in Atlanta
- Proceedings
from June 2006 ACIP meeting now online
- American Public
Health Association (APHA) annual meeting planned for Boston on November
4-8
- New: September
28 issue of IAC's Hep Express e-newsletter now online
- CDC updates
online adult and adolescent vaccine quiz for public
- New: IAC website
posts Turkish-language translations of five patient-education pieces
- 2006-07 Spanish-language
VIS for inactivated influenza vaccine now available in audio and
video formats
|
| |
|
Abbreviations |
|
|
AAFP, American Academy
of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory
Committee on Immunization Practices; CDC, Centers for Disease Control
and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NIP, National
Immunization Program; VIS, Vaccine Information Statement; VPD, vaccine-preventable
disease; WHO, World Health Organization. |
| |
| Issue 623: October 2,
2006 |
|
|
| 1. |
October 2,
2006
STUDY OF MORE THAN 2 MILLION CHILDREN FAILS TO LINK MMR OR DTP VACCINATION WITH
INCREASED RISK FOR ENCEPHALOPATHY
A study of the health
records of more than 2 million children in four U.S. health maintenance
organizations revealed that those who were vaccinated with MMR or DTP
vaccine were no more likely to develop encephalopathy than were children
who had not received the vaccines. Titled "Encephalopathy after
whole-cell pertussis or measles vaccination: Lack of evidence for a causal
association in a retrospective case-control study," the study results
were published in the September 2006 issue of the Pediatric Infectious
Disease Journal (PIDJ). The abstract is reprinted below in its entirety.
ABSTRACT:
Background: Whole-cell pertussis (wP) and measles vaccines are effective in preventing
disease but have also been suspected of increasing the risk of encephalopathy
or encephalitis. Although many countries now use acellular pertussis vaccines,
wP vaccine is still widely used in the developing world. It is therefore
important to evaluate whether wP vaccine increases the risk of neurologic
disorders.
Methods: A retrospective case-control study was performed at 4 health maintenance
organizations. Records from January 1, 1981, through December 31, 1995, were
examined to identify children aged 0 to 6 years old hospitalized with encephalopathy
or related conditions. The cause of the encephalopathy was categorized as known,
unknown, or suspected but unconfirmed. Up to 3 controls were matched to each
case. Conditional logistic regression was used to analyze the relative risk of
encephalopathy after vaccination with diphtheria-tetanus-pertussis (DTP) or measles-mumps-rubella
(MMR) vaccines in the 90 days before disease onset as defined by chart review
compared with an equivalent period among controls indexed by matching on case
onset date.
Results: Four-hundred fifty-two cases were identified. Cases were no more likely
than controls to have received either vaccine during the 90 days before disease
onset. When encephalopathies of known etiology were excluded, the odds ratio
for case children having received DTP within 7 days before onset of disease was
1.22 (95% confidence interval [CI] = 0.45-3.31, P = 0.693) compared with control
children. For MMR in the 90 days before onset of encephalopathy, the odds ratio
was 1.23 (95% confidence interval = 0.51-2.98, P = 0.647).
Conclusions: In this study of more than 2 million children, DTP and MMR vaccines
were not associated with an increased risk of encephalopathy after vaccination.
To access the abstract,
go to the PIDJ homepage at: http://www.pidj.com Click
on the Archive tab at the top of the page. You will be taken to an index of volumes.
Click on the link titled September 2006 to go to the issue's table of contents.
Under the heading Original Studies, click in box 768 to the left of the article
titles. Then, click on the Abstract link to the right of the pertinent title.
The full text is available to PIDJ subscribers.
|
| |
| |
| |
| |
| 2. |
October 2,
2006
HOW'S YOUR STATE DOING? 2005 BRFSS PROVIDES INFLUENZA AND PNEUMOCOCCAL VACCINATION
RATES FOR ADULTS AGE 65 AND OLDER
CDC's Behavioral Risk
Factor Surveillance System (BRFSS) web section recently posted immunization
data on the influenza and pneumococcal vaccination rates for adults age
65 and older in 2005. The 2005 survey showed that nationwide, 65.7 percent
of respondents reported having received influenza vaccination within
the past year, and 65.9 percent reported ever having received pneumococcal
vaccination.
To access influenza
vaccination rates for all states, go to:
http://apps.nccd.cdc.gov/brfss/list.asp?cat=IM&yr=2005&qkey=4407&state=US
To access pneumococcal vaccination rates for all states, go to:
http://apps.nccd.cdc.gov/brfss/list.asp?cat=IM&yr=2005&qkey=4408&state=US |
| |
| |
| |
| 3. |
October
2, 2006
CONGRATULATIONS! DR. NANCY COX, CDC INFLUENZA EXPERT, SELECTED AS FEDERAL EMPLOYEE
OF THE YEAR
On September
27, Dr. Nancy Cox, the chief of CDC's Influenza Division, was honored
as Federal Employee of the Year. Dr. Cox was selected for the honor
by the Partnership for Public Service for her work in helping the United
States and the world prepare for a potential influenza pandemic. The
partnership is a nongovernmental organization that works to make the
government an employer of choice for talented, dedicated
Americans.
On September 28, CDC issued a press release about Dr. Cox. A portion of it is
reprinted below.
. . . . Dr. Cox received a bachelor's degree in bacteriology from Iowa State
University in 1970. She was one of about 30 American students awarded a Marshall
Scholarship to study in England at the University of Cambridge, where in 1975
she earned a doctoral degree in virology with a dissertation that focused on
influenza virus/host interactions.
The recipient of numerous scientific and achievement awards, Dr. Cox is a member
of the editorial board for the journal Lancet Infectious Diseases. She is also
a founding member of the International Society for Influenza and other Respiratory
Diseases and is the author and co-author of more than 175 research articles,
reviews, and book chapters. For her leadership in preparing the United States
and the international community for a potential influenza pandemic, Dr. Cox was
also recognized in 2006 by Time and Newsweek magazines. Time magazine named her
one of 2006's 100 Most Influential People of the Year, and Newsweek magazine
honored her as one of the "15 People who Make America Great."
To access the
complete press release, go to:
http://www.cdc.gov/od/oc/media/pressrel/r060928.htm |
| |
| |
| |
| 4. |
October 2, 2006
CARDIOLOGISTS STRONGLY ENCOURAGED TO VACCINATE THEIR PATIENTS WITH INACTIVATED
INFLUENZA VACCINE
On September
19, the website of the American Heart Association (AHA) posted a press
release titled "Annual flu shot may protect cardiovascular disease
patents." The press release is based on an advisory for secondary
prevention for patients with coronary and other atherosclerotic vascular
disease. Developed by AHA in conjunction with the American College
of Cardiology (ACC), the advisory recommends that patients with cardiovascular
disease receive influenza vaccination.
Portions of the September 19 press release are reprinted below. A link to the
abstract of an article (published in the journal Circulation, 5/16/06) outlining
the advisory appears at the end of this IAC Express article.
The American Heart Association and the American College of Cardiology are asking
heart doctors to do something they may not normally do—give flu shots to their
patients. However, patients with cardiovascular disease should not get the nasal-spray
flu vaccine.
Patients with cardiovascular disease are more likely to die from influenza than
patients with any other chronic condition, according to the new AHA/ACC scientific
advisory.
Studies have found that annual flu vaccinations can prevent death in adults and
children with chronic conditions of the cardiovascular system. But only one in
three adults with cardiovascular disease was vaccinated against flu in 2005.
"If we vaccinated at least 60 percent of the 13.2 million people with coronary
heart disease in the United States against influenza, we could prevent hundreds
of deaths and thousands of cases of flu each year," said Matthew M. Davis,
MD, lead author of the advisory and associate professor of pediatrics, internal
medicine, and public policy at the University of Michigan in Ann Arbor. . . .
A visit to the cardiologist presents a good, but often missed, opportunity to
get vaccinated, Davis said. "Most people with heart disease visit their
cardiologists during the time when they should get the flu shot, but only about
half of cardiologists in the United States stock the vaccine in their clinics."
. . . . [T]he most effective way to increase the number of cardiovascular patients
vaccinated is to have flu vaccine available in all cardiology practices and to
have physicians strongly recommend the vaccine to their patients. Most insurance
plans cover flu vaccinations. . . .
To access the
complete press release, go to:
http://www.americanheart.org/presenter.jhtml?identifier=3042167
To access the abstract of the article on the of AHA/ACC advisory, go to:
http://circ.ahajournals.org/cgi/content/abstract/CIRCULATIONAHA.106.178242v1 |
| |
| |
| |
| 5. |
October
2, 2006
UPDATED FOR 2006-07: ONLINE INFORMATION AND GUIDANCE ON INFLUENZA VACCINE,
ANTIVIRALS, LAB DIAGNOSIS, AND MORE
CDC
recently updated six pages on its Influenza web section:
- Questions & answers:
Thimerosal-containing influenza vaccine (9/26/06)
- Antiviral medications
for influenza (9/26/06)
- Lab diagnosis
of influenza (9/26/06)
- I practice healthy
habits (poster; 9/22/06)
- I had to take
a flu break (poster; 9/22/06)
- Interim guidance
for influenza diagnostic testing during the 2006-07 influenza season
(9/22/06)
To access these resources,
go to: http://www.cdc.gov/flu/whatsnew.htm#updated and
click on the pertinent link.
To access a broad range of continually updated information on seasonal influenza,
avian influenza, and pandemic influenza, go to: http://www.cdc.gov/flu |
| |
| |
| |
| 6. |
October 2, 2006
ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) MEETING SCHEDULED FOR OCTOBER
25-26 IN ATLANTA
[The following
is cross posted from IAC's Hep Express electronic newsletter, September
28, 2006]
The Advisory Committee on Immunization Practices (ACIP) will hold its next meeting
on October 25-26 at CDC's Clifton Road campus in Atlanta. The meeting is open
to the general public.
To speed security clearance, ACIP attendees (participants and visitors) should
register online. All non-U.S. citizens are required to register online AND complete
the Access Request Form at least three weeks in advance of an ACIP meeting (i.e.,
by October 2 for the October 25-26 meeting). Non-U.S. citizens will not be allowed
to register on site.
To register
online, go to:
http://www2.cdc.gov/nip/ACIP/octoberRegistration.asp
To access a ready-to-print (PDF) version of the draft meeting agenda, go to:
http://www.cdc.gov/nip/ACIP/agendas/agenda-oct06.pdf
For more information, go to: http://www.cdc.gov/nip/ACIP/dates.htm or
contact Dee Gardner by phone at (404) 639-8836 or by email at DGardner@cdc.gov |
| |
| |
| |
| 7. |
October
2, 2006
PROCEEDINGS FROM JUNE 2006 ACIP MEETING NOW ONLINE
The CDC website
recently posted the Record of the Proceedings of ACIP's June
29–30 meeting.
To access a
ready-to-print (PDF) version of the proceedings, go
to: http://www.cdc.gov/nip/ACIP/minutes/acip-min-jun06.pdf |
| |
| |
| |
| 8. |
October
2, 2006
AMERICAN PUBLIC HEALTH ASSOCIATION (APHA) ANNUAL MEETING PLANNED FOR BOSTON ON
NOVEMBER 4-8
[The following
is cross posted from IAC's Hep Express electronic newsletter, September
28, 2006]
Scheduled for November 4-8 at the new Boston Convention and Exhibition Center
(near the waterfront), the APHA annual meeting offers attendees a platform to
share successes and failures, discover exceptional best practices, and learn
from expert colleagues and the latest research in the field.
For comprehensive
information, go to: www.apha.org/meetings or
call APHA's main phone number at (202) 777-2742. |
| |
| |
| |
|
9. |
October
2, 2006
NEW: SEPTEMBER 28 ISSUE OF IAC'S HEP EXPRESS E-NEWSLETTER NOW ONLINE The September
28 issue of Hep Express, an electronic newsletter published by IAC,
is now available online. It is intended for health professionals,
program planners, and advocates involved in prevention, screening,
and treatment of viral hepatitis. The titles of two articles that
will be of particular interest to IAC Express readers are (1) Check
out IAC's hepatitis prevention program website for new and updated
programmatic information and (2) New York state's 2006 program manual
for perinatal hepatitis B prevention now available online.
IAC Express has already covered some of the information presented in the September
28 Hep Express; titles of articles we have not yet covered follow.
- Read the Infectious
Diseases in Corrections Report (formerly called HEPP Report)
- Visit the Hepatitis
B Foundation website for featured stories that include information
on rising liver cancer rates
- Check out the
website of the National Nurses Advisory Council for Liver Wellness & Viral
Hepatitis
- New website supports
people living with chronic hepatitis B with information about the
disease, testing, and treatment
- Get an international
perspective on safe injection practices from SIGNpost newsletter
and WHO web sections
- Annual SIGN Injection
Safety and Infection Control meeting to be held in Mexico City on
October 23-25
To access the September
28 issue, go to:
http://www.hepprograms.org/hepexpress/issue48.asp
To sign up for a free subscription to Hep Express, go to:
http://www.hepprograms.org/hepexpress/signup.asp
To access previous issues of Hep Express, go to:
http://www.hepprograms.org/hepexpress |
| |
| |
| |
| 10. |
October
2, 2006
CDC UPDATES ONLINE ADULT AND ADOLESCENT VACCINE QUIZ FOR PUBLIC
On September 14, CDC updated its online adult and adolescent vaccine quiz, "What
vaccines do you need?" The quiz now reflects information about newly recommended
vaccines (e.g., Tdap) and vaccines for which updated recommendations have been
issued (e.g., influenza immunization of healthcare workers).
Designed to provide vaccine information for persons ages 11 years and older,
the quiz asks the respondent to answer simple prompts about their demographics,
lifestyle and work, and health status. A respondent who completes the quiz immediately
receives an electronic chart that lists the vaccines specifically recommended
for him or her at the time of taking the quiz.
Respondents are encouraged to print the chart and take it to their healthcare
provider, along with a comprehensive chart (also printable) of information about
all vaccines currently recommended for adults and adolescents.
To access the updated quiz, go to:
http://www2.cdc.gov/nip/adultimmsched |
| |
| 11. |
October
2, 2006
NEW: IAC WEBSITE POSTS TURKISH-LANGUAGE TRANSLATIONS OF FIVE PATIENT-EDUCATION
PIECES
The IAC website recently posted Turkish-language translations of current versions
of five of its print materials for patients. We are grateful to Dr. Mustafa Kozanoglu
and Dr. Murat Serbest for the translations.
To access ready-to-print (PDF) versions of the newly translated pieces, click
on the links below:
(1) Are you 11-19 years old? Then you need to be vaccinated! (updated 2/06)
Turkish: http://www.immunize.org/catg.d/p4020tu.pdf
English: http://www.immunize.org/catg.d/11teens8.pdf
(2) Screening questionnaire for adult immunization (updated 9/06)
Turkish: http://www.immunize.org/catg.d/p4065tu.pdf
English: http://www.immunize.org/catg.d/p4065scr.pdf
(3) Screening questionnaire for child and teen immunization (updated 9/06)
Turkish: http://www.immunize.org/catg.d/p4060tu.pdf
English: http://www.immunize.org/catg.d/p4060scr.pdf
(4) Immunization for babies: A guide for parents (updated 5/06)
Turkish: http://www.immunize.org/catg.d/p4010tu.pdf
English: http://www.immunize.org/catg.d/p4010imm.pdf
(5) After the shots . . . what to do if your child has discomfort (updated 9/04)
Turkish: http://www.immunize.org/catg.d/4015tu.pdf
English: http://www.immunize.org/catg.d/p4015.pdf |
| |
| 12. |
October
2, 2006
2006-07 SPANISH-LANGUAGE VIS FOR INACTIVATED INFLUENZA VACCINE NOW AVAILABLE
IN AUDIO AND VIDEO FORMATS
The Spanish-language 2006-07 VIS for injectable trivalent inactivated influenza
vaccine (TIV; dated 6/30/06) is now available on IAC's website in audio, multimedia,
and web-page video formats. These formats are intended for use with low-literacy,
Spanish-speaking patients. The web-page video is specifically tailored to be
able to work for people who have slow Internet connections.
IAC is grateful to Healthy Roads Media for providing these alternative versions.
Healthy Roads Media offers health information in a variety of formats and languages.
For information, go to: http://www.healthyroadsmedia.org
To access any of the alternative versions of the Spanish-language VIS for TIV,
go to: http://www.immunize.org/vis/#influenza In
the Inactivated Influenza Vaccine section, either click on the link titled "Spanish
(audio VIS*)" or on the link titled "Spanish (multimedia "movie" VIS*)." Either
link will bring you to a menu on the Healthy Roads Media website where you can
choose among audio, multimedia, or web-page formats.
To access a ready-to-print (PDF) hard-copy version of the Spanish-language VIS
for TIV, go to:
http://www.immunize.org/vis/spflu06.pdf
For information about the use of VISs, and for VISs in a total of 33 languages,
visit IAC's VIS web section at http://www.immunize.org/vis |
|
